Products & safety
Hair dyes: colour categories, sensitivity testing and different kinds of risk
On this page
Hair dyes change hair colour. FDA distinguishes hair-colour regulation by the colouring materials and intended use, rather than judging safety from the shade or an appealing label. The shade alone does not identify ingredients, allergy risk or the appropriate application site.[1]
Different product properties answer different questions
| Category | What it does or measures | Boundary |
|---|---|---|
| Nonpermanent versus permanent colour | Direct staining versus reaction-based pigment formation | Colour mechanism does not establish freedom from allergy[4] |
| Permanent dye exposure in a cohort | Reported personal use over time | Not random assignment or a test of every current formula[5] |
| Manufacturer sensitivity test | A precaution before application | Not a guarantee that a reaction cannot occur[1] |
| Clinical patch testing | Assessment of particular contact allergens | Different from judging the resulting hair colour[2] |
Read the application boundary before choosing a colour
FDA advises following the product’s instructions, using gloves and performing the advised skin sensitivity test each time. Hair dye should not be used to colour eyelashes or eyebrows: those sites introduce different eye hazards. Do not leave the product on longer than directed or assume mixing products improves safety. The finished formulation and intended site matter alongside the ingredient list. A dye intended for scalp hair is not interchangeable with a product for another body site.[1]
Black henna creates a specific sensitisation concern
FDA explains that products marketed as black henna can contain para-phenylenediamine, or PPD, a hair-dye ingredient associated with dangerous skin reactions. Henna approval for hair does not authorise every skin-tattoo use, and a botanical-sounding description cannot establish the mixture’s contents. A previous black-henna reaction is relevant to future exposure to PPD-containing dyes. This concern is about ingredients and sensitisation, rather than assuming all products called henna have an identical composition or that all plant-derived colouring is harmless.[3]
Evidence & uncertainty
A local skin reaction and a possible long-term cancer association are different outcomes. NCI separates personal dye use from the repeated exposures of hairdressers and notes mixed findings across cancer types. An occupational hazard finding cannot simply be converted into the risk from one consumer application.[4]
Selected-source overview · Independent review pendingPublished questions
Can ordinary hair dye safely become an eyebrow or eyelash dye?
Selected-source overview · Independent review pending. Read the evidence context.
No. FDA warns against using hair dyes on eyebrows or eyelashes. Intended site and eye exposure matter; the scalp-hair label does not authorise another route.[1]
Evidence behind this answer
- Hair Dyes
official guidance · 2025
Selected original guidance or document passages inspected; no independent full-document appraisal · Safety precautions, colouring-material regulation, intended site and shade
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does a negative hair-dye sensitivity test guarantee no later reaction?
Selected-source overview · Independent review pending. Read the evidence context.
No. The historical European opinion identified uncertain test sensitivity and sensitisation concerns. A negative consumer test is not a certificate that full application cannot cause a reaction.[6]
Evidence behind this answer
- Sensitivity to Hair Dyes: Consumer Self Testing
scientific committee opinion · 2007
Selected original guidance or document passages inspected; no independent full-document appraisal · Selected historical opinion classification and conclusions: test sensitivity and sensitisation limits
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does the name black henna guarantee a pure plant colouring product?
Selected-source overview · Independent review pending. Read the evidence context.
No. FDA describes black-henna mixtures containing PPD. Botanical wording does not establish composition, and previous exposure can matter to later hair-dye allergy.[3]
Evidence behind this answer
- Temporary Tattoos, Henna/Mehndi and Black Henna
official guidance · 2024
Selected original guidance or document passages inspected; no independent full-document appraisal · PPD-containing mixtures; intended-site limits and sensitisation
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Must a hair-dye reaction appear immediately?
Selected-source overview · Independent review pending. Read the evidence context.
No. NHS says symptoms may take up to 72 hours. Worsening symptoms need advice; breathing difficulty or sudden mouth/throat swelling requires emergency help.[2]
Evidence behind this answer
- Hair dye reactions
official guidance · 2025
Selected original guidance or document passages inspected; no independent full-document appraisal · Delayed symptoms, clinical patch testing, washing after reaction and 999 escalation
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Did the long-term hair-dye cohort randomly assign women to dye their hair?
Selected-source overview · Independent review pending. Read the evidence context.
No. It analysed reported exposure over time in US nurses. Confounding, changing formulations and population differences limit causal interpretation and current-product predictions.[5]
Evidence behind this answer
- Permanent hair dyes and cancer risk and mortality in US women
prospective cohort · 2020
Selected original guidance or document passages inspected; no independent full-document appraisal · Selected original abstract, methods and results:117,200 nurses,36 years and overall/subtype comparisons
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Is a hairdresser exposure finding a personal risk estimate for one colouring session?
Selected-source overview · Independent review pending. Read the evidence context.
No. NCI distinguishes occupational and personal use. Repeated workplace exposures and one consumer application are different exposure patterns and cannot share a simple risk estimate.[4]
Evidence behind this answer
- Hair Dyes, Other Hair Products and Cancer Risk
official guidance · 2022
Selected original guidance or document passages inspected; no independent full-document appraisal · Personal versus occupational exposure, older formulations and inconsistent site-specific findings
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
A negative consumer test is not an allergy certificate
The European Scientific Committee’s 2007 opinion examined consumer self-testing and identified uncertain sensitivity and the possibility of sensitisation through testing. This is a historical scientific opinion, not a current instruction to disregard a manufacturer’s precautions. It explains why a negative home result cannot guarantee that later full application is reaction-free. Clinical patch testing uses a different assessment context. Someone with a previous reaction should seek appropriate assessment rather than repeatedly exposing irritated skin in an attempt to prove a dye is acceptable.[6]
Long follow-up does not eliminate exposure uncertainty
The 2020 Nurses’ Health Study analysis included 117,200 US women initially free of cancer and followed them for 36 years. It found no significant increase in overall solid cancer excluding non-melanoma skin cancers, or haematopoietic cancer among ever-users of permanent dye, while some subtype findings differed. Exposure was reported rather than randomly assigned; formulations and other behaviours can change over decades. The largely White nurse population limits generalisation. This study cannot certify a particular current bottle as safe, nor establish that every subgroup association is causal.[5]
Broad labels conceal differences in study populations
NCI’s overview describes inconsistent evidence across cancer sites and distinguishes older formulations, personal use and occupational exposure. Different studies may define ever use, frequent use or specific dye types differently. A reassuring overall finding and a concerning subgroup result can coexist without answering exactly the same exposure question. The overview and studies it discusses share underlying evidence and should not be counted as independent replications. Allergy precautions address a more immediate outcome than the uncertain long-term associations.[4]
Stop a reaction rather than waiting for the colour to develop
NHS guidance says symptoms can take up to 72 hours to appear and may be harder to recognise as redness on darker skin. Stop use and wash the hair and scalp if a reaction develops; worsening symptoms need clinical advice. Sudden mouth, tongue or throat swelling, trouble breathing or swallowing, or collapse-type symptoms need emergency help. These cues concern potentially serious reactions, not a claim that every itchy scalp has the same cause. The UK emergency route is 999; use the applicable local service elsewhere.[2]
References
- Hair Dyes
Official guidance
FDA · Content/publication date: 2025
Accessed: 2026-10-14 UTC · Selected original guidance or document passages inspected; no independent full-document appraisal
Cited sections: Safety precautions, colouring-material regulation, intended site and shade - Hair dye reactions
Official guidance
NHS · Content/publication date: 2025
Accessed: 2026-10-14 UTC · Selected original guidance or document passages inspected; no independent full-document appraisal
Cited sections: Delayed symptoms, clinical patch testing, washing after reaction and 999 escalation - Temporary Tattoos, Henna/Mehndi and Black Henna
Official guidance
FDA · Content/publication date: 2024
Accessed: 2026-10-14 UTC · Selected original guidance or document passages inspected; no independent full-document appraisal
Cited sections: PPD-containing mixtures; intended-site limits and sensitisation - Hair Dyes, Other Hair Products and Cancer Risk
Official guidance
National Cancer Institute · Content/publication date: 2022
Accessed: 2026-10-14 UTC · Selected original guidance or document passages inspected; no independent full-document appraisal
Cited sections: Personal versus occupational exposure, older formulations and inconsistent site-specific findings - Permanent hair dyes and cancer risk and mortality in US women
Prospective cohort
Zhang et al. · Content/publication date: 2020
Accessed: 2026-10-14 UTC · Selected original guidance or document passages inspected; no independent full-document appraisal
Cited sections: Selected original abstract, methods and results:117,200 nurses,36 years and overall/subtype comparisons - Sensitivity to Hair Dyes: Consumer Self Testing
Scientific committee opinion
European Scientific Committee on Consumer Products · Content/publication date: 2007
Accessed: 2026-10-14 UTC · Selected original guidance or document passages inspected; no independent full-document appraisal
Cited sections: Selected historical opinion classification and conclusions: test sensitivity and sensitisation limitsHistorical scientific appraisal, not a current regulatory prohibition or personal testing protocol.
Scope & review
- Population
- General consumers; children, clinical patients and occupational exposure are identified separately
- Exposure or intervention
- Product functions, ingredient-specific claims and practical personal-care boundaries
- Comparison
- Colour duration versus ingredient risk; home precautions versus clinical allergy testing; personal versus occupational cancer exposure
- Outcomes
- Appearance, handling, source-specific clinical outcomes, irritation and other identified harms
- Timeframe
- Current guidance checked 14 October 2026 UTC; original study populations and timeframes are stated separately
- Jurisdiction
- Selected US and UK guidance and original international research; ingredient, route, formulation and jurisdiction remain source-specific
Selected-source educational explanation. Official guidance, original study findings and editorial interpretation are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review has been completed.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-14 UTC: Added a sourced explanation in a bounded ten-article batch; qualified review remains pending.
What this article still leaves open
- Which ingredient caused a previous reaction, and what does clinical assessment establish?
- How do current formulations and more diverse populations alter long-term exposure findings?
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.